CR Bard Inc. (BCR) Stock Research, Analysis & News

Quick Analysis on CR Bard Inc. (BCR) Stock as of August 24, 2019

The Stock pays no dividend
Average trading volume is relatively low at 0
(See more information about CR Bard Inc. (BCR) Stock below)

CR Bard Inc. (BCR) Stock Profile Summary

C. R. Bard, Inc., together with its subsidiaries, engages in the design, manufacture, packaging, distribution, and sale of medical, surgical, diagnostic, and patient care devices worldwide. It offers vascular, urology, oncology, and surgical specialty products. The companys vascular products include percutaneous transluminal angioplasty catheters, guidewires, introducers, and accessories; peripheral vascular stents and stent grafts, vena cava filters, and biopsy devices; electrophysiology products, such as electrophysiology diagnostic, therapeutic, and temporary pacing electrode catheters, as well as laboratory systems; and fabrics, meshes, and implantable vascular grafts. Its urology products comprise infection control Foley catheters to reduce the rate of urinary tract infections; surgical slings used to treat stress urinary incontinence; natural and synthetic devices to treat pelvic floor and vaginal prolapse; brachytherapy services, devices, and radioactive seeds used to treat prostate cancer; intermittent urinary drainage catheters, and urine monitoring and collection systems; ureteral stents; specialty devices for ureteroscopic procedures and stone removal; fecal incontinence products; and catheter stabilization devices. The company offers various devices to treat and manage cancers, and other diseases and disorders, including specialty access catheters, ports, vascular access ultrasound devices, and enteral feeding devices. Its surgical specialty products include implanted patches and fixation systems for hernia and other soft tissue repairs; irrigation devices for orthopedic, laparoscopic, and gynecological procedures; and products for topical hemostasis. C. R. Bard sells its products directly and through distributors to hospitals, individual health care professionals, extended care facilities, and alternate site facilities. The company was founded in 1907 and is based in Murray Hill, New Jersey.

CR Bard Inc. (BCR) Stock Key Statistics Research and Analysis as of August 24, 2019

CR Bard Inc. (BCR) Stock Competitor Research and Analysis

Baxter International Inc. (BAX)Boston Scientific Corporation (BSX)
Unitedhealth Group, Inc. (UNH)WellPoint Inc. (WLP)
Aetna Inc. (AET)

Mutual Funds with CR Bard Inc. (BCR) Stock in its top 10 holdings

FundCategoryBCR Holding Percentage
Thrivent Mid Cap Stock AMid-Cap Blend2.73%
Advance Capital I Equity Growth RetailMid-Cap Value1.71%
Smith Group Large Cap Core Growth InstlLarge Blend2.68%
Boston Trust Asset ManagementAllocation--70% to 85% Equity2.07%
Boston Trust EquityLarge Blend2.66%
Boston Trust MidcapMid-Cap Growth1.68%
CRM Mid Cap Value InstlMid-Cap Blend2.57%
Dreyfus Global Stock AWorld Stock2.22%
Dreyfus US Equity ALarge Growth2.45%

ETFs with CR Bard Inc. (BCR) Stock in its top 10 holdings

Stock Research on CR Bard Inc. (BCR)

Latest Market News on CR Bard Inc. (BCR)


Click here to find the latest news on CR Bard Inc. (BCR)

Looking for Market Opportunties?


Today's Most Active Stocks
Today's Biggest Price % Gainers
Today's Biggest Price % Losers
Today's Unusual Rising Volume Stocks
Today's Unusual Falling Volume Stocks
Research Reports
Earning Calendar
ETF Center

See other companies in the same industry

Baxter International Inc. (BAX)
Boston Scientific Corporation (BSX)
Unitedhealth Group, Inc. (UNH)
WellPoint Inc. (WLP)
Aetna Inc. (AET)